Trial Profile
A study to evaluate the effect of CYP2C19 and POR genotypes on the pharmacokinetic parameters of clobazam in Japanese patients with epilepsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Clobazam (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- 18 Dec 2015 New trial record